πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors β€” phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β€” searchable for business development and competitive intelligence.

1,413 results for β€œChinese” Clear

  1. Sintilimab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lung Neoplasms

    phase 2 small molecule active

    1 trial

  2. Sintilimab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Anti-PD-1 Antibody

    phase 2 small molecule active

    1 trial

  3. Sintilimab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Non-small Cell Lung Cancer Stage III

    phase 2 small molecule active

    1 trial

  4. Sintilimab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Renal Cell Carcinoma

    phase 2 small molecule active

    1 trial

  5. Sintilimab (approved)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatocellular Carcinoma (HCC)

    phase 2 small molecule active

    1 trial

  6. Sintilimab in combination with Multimodality Radiotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Nasopharyngeal Carcinoma

    phase 2 small molecule active

    1 trial

  7. Sintilimab injection plus Inlyta treatment

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Carcinoma, Renal Cell

    phase 2 small molecule active

    1 trial

  8. Sirolimus

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Kaposiform Hemangioendothelioma

    phase 2 small molecule active

    1 trial

  9. Sirolimus

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Plastic Bronchitis

    phase 2 small molecule active

    1 trial

  10. Sirolimus

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hemangioendothelioma

    phase 2 small molecule active

    1 trial

  11. Spermidine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Radiation-induced Xerostomia

    phase 2 small molecule active

    1 trial

  12. Spray of spirulina derivatives

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Radiation-induced Oral Mucositis

    phase 2 small molecule active

    1 trial

  13. Streptococcus salivarius K12

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Head and Neck Squamous Cell Carcinoma

    phase 2 small molecule completed

    1 trial

  14. Sunvozertinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Potentially Resectable EGFR Exon 20 Insertion Non-Small Cell Lung Cancer

    phase 2 small molecule active

    1 trial

  15. Surufatinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Biliary Tract Cancer

    phase 2 small molecule active

    1 trial

  16. TAVR

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Aortic Valve Disease

    phase 2 other active

    1 trial

  17. TGRX-326

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Non-small Cell Lung Cancer

    phase 2 small molecule active

    1 trial

  18. TNFΞ± Monoclonal Antibody

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Spinal Cord Injuries

    phase 2 small molecule active

    1 trial

  19. TNTL capsule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Accidental Exposure While Preparing Drug for Administration

    phase 2 small molecule completed

    1 trial

  20. TQB3616 Capsules Combined With Abiraterone Acetate Plus Prednisone

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Prostatic Neoplasms, Castration-Resistant

    phase 2 small molecule active

    1 trial

  21. TQC2731 injection

    Shanghai University of Traditional Chinese Medicine

    Chronic Obstructive Pulmonary Disease

    phase 2 small molecule active

    1 trial

  22. TQH2722 injection

    Shanghai University of Traditional Chinese Medicine

    Seasonal Allergic Rhinitis

    phase 2 small molecule active

    1 trial

  23. Tacrolimus ointment

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Tacrolimus, Kaposiform Hemangioendothelioma, Tufted Angioma

    phase 2 small molecule active

    1 trial

  24. Tangweian Recipe

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Diabetic Gastroenteropathy

    phase 2 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β€” verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources